BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 37111111)

  • 21. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes.
    Xie Y; Kong W; Wang X; Wu Z
    BMC Endocr Disord; 2022 Aug; 22(1):220. PubMed ID: 36045348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severity of metabolic syndrome is greater among nonalcoholic adults with elevated ALT and advanced fibrosis.
    DeBoer MD; Lin B; Filipp SL; Cusi K; Gurka MJ
    Nutr Res; 2021 Apr; 88():34-43. PubMed ID: 33743323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of iron status with non-alcoholic fatty liver disease and liver fibrosis in US adults: a cross-sectional study from NHANES 2017-2018.
    Tan L; Zhou Q; Liu J; Liu Z; Shi R
    Food Funct; 2023 Jun; 14(12):5653-5662. PubMed ID: 37249386
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum vitamin D is associated with ultrasound-defined hepatic fibrosis.
    Jiang R; Zhou Y; Han L; Hong Z
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102228. PubMed ID: 37865224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound.
    Ding Y; Jiang L; Wang Q; Zhao W; Zhou X; Lu J; Tian T; Yu C; Xu X; Guo W; Zhang Q; Song C
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101951. PubMed ID: 35605893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Neutrophil-to-Lymphocyte Ratio with Inflammatory Activity and Fibrosis in Non-alcoholic Fatty Liver Disease.
    WenYi J; Ting Q; PiaoPiao Y; JinMing W
    Turk J Gastroenterol; 2022 Jan; 33(1):53-61. PubMed ID: 35040788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
    Zhang X; Heredia NI; Balakrishnan M; Thrift AP
    PLoS One; 2021; 16(6):e0252164. PubMed ID: 34081733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
    Shelley K; Articolo A; Luthra R; Charlton M
    BMC Gastroenterol; 2023 May; 23(1):160. PubMed ID: 37208593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the neutrophil percentage-to-albumin ratio as a biomarker for predicting recurrence of first-episode ischemic stroke.
    Yang D; Niu C; Li P; Du X; Zhao M; Jing W
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107485. PubMed ID: 37966092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease.
    Zhao Y; Li H
    Scand J Gastroenterol; 2022 Jul; 57(7):872-877. PubMed ID: 35189786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review.
    Peng Y; Li Y; He Y; Wei Q; Xie Q; Zhang L; Xia Y; Zhou X; Zhang L; Feng X; Chen K; Chen S; Chen W; Long Q; Chai J
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):503-513. PubMed ID: 29629626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults.
    Yang N; Lu Y; Cao L; Lu M
    J Clin Lab Anal; 2022 Feb; 36(2):e24225. PubMed ID: 34997649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.
    Kleiner DE; Brunt EM; Wilson LA; Behling C; Guy C; Contos M; Cummings O; Yeh M; Gill R; Chalasani N; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Terrault N; Kowdley K; Loomba R; Belt P; Tonascia J; Lavine JE; Sanyal AJ;
    JAMA Netw Open; 2019 Oct; 2(10):e1912565. PubMed ID: 31584681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver fibrosis markers of nonalcoholic steatohepatitis.
    Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
    World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
    Vuille-Lessard É; Lebouché B; Lennox L; Routy JP; Costiniuk CT; Pexos C; Giannakis A; Szabo J; Klein MB; Sebastiani G
    AIDS; 2016 Nov; 30(17):2635-2643. PubMed ID: 27603289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes.
    Lee CH; Seto WK; Lui DT; Fong CH; Wan HY; Cheung CY; Chow WS; Woo YC; Yuen MF; Xu A; Lam KS
    Diabetes Care; 2021 Sep; 44(9):2089-2097. PubMed ID: 34183428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.